Sources | Names Used |
---|---|
CCLE, FIMM | Vandetanib |
CTRPv2 | vandetanib |
PharmacoGx | Vandetanib |
Database | Identifier |
---|---|
Smiles: | CN1CCC(CC1)COC2=C(C=C3C(=C2)N=CN=C3NC4=C(C=C(C=C4)Br)F)OC |
Inchikey: | UHTHHESEBZOYNR-UHFFFAOYSA-N |
Pubchem: | 3081361 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | FYB | CCLE | pan-cancer | AAC | 0.21 | 1e-05 |
mRNA | LETM2 | CCLE | pan-cancer | AAC | -0.2 | 1e-05 |
mRNA | CTNND1 | CCLE | pan-cancer | AAC | 0.28 | 1e-05 |
mRNA | MOB3C | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
mRNA | CXCL16 | CCLE | pan-cancer | AAC | 0.24 | 1e-05 |
mRNA | KLF8 | CCLE | pan-cancer | AAC | 0.21 | 1e-05 |
mRNA | LSR | CCLE | pan-cancer | AAC | 0.26 | 1e-05 |
mRNA | TNK1 | CCLE | pan-cancer | AAC | 0.25 | 1e-05 |
mRNA | ENOX1 | CCLE | pan-cancer | AAC | -0.22 | 2e-05 |
mRNA | SH2D3A | CCLE | pan-cancer | AAC | 0.24 | 2e-05 |